In a report released yesterday, Kristen Kluska from Cantor Fitzgerald maintained a Buy rating on Amicus (FOLD – Research Report), with a price ...

Intra-Cellular Therapies (NASDAQ:ITCI – Get Free Report) was upgraded by equities research analysts at Cantor Fitzgerald from ...

In a report released yesterday, Kristen Kluska from Cantor Fitzgerald maintained a Buy rating on PTC Therapeutics (PTCT – Research Report), ...

Fintel reports that on January 13, 2025, Cantor Fitzgerald initiated coverage of Nova (NasdaqGS:NVMI) with a Overweight ...

Fintel reports that on January 13, 2025, Cantor Fitzgerald initiated coverage of Onto Innovation (NYSE:ONTO) with a ...

IDEAYA Biosciences (NASDAQ:IDYA – Get Free Report)‘s stock had its “overweight” rating restated by Cantor Fitzgerald in a ...

Cantor Fitzgerald is charged with violating antifraud and proxy provisions. Former Comtech CEO is charged with insider trading ahead of negative earnings. The Securities and Exchange Commission on ...

WASHINGTON, Dec 12 (Reuters) - Wall Street brokerage Cantor Fitzgerald has agreed to pay a $6.75 million penalty to settle Securities and Exchange Commission charges that it misled investors in ...

Cantor Fitzgerald reiterates an Overweight rating on Avita Medical (RCEL) following the company receiving FDA premarket approval for RECELL GO Mini, its miniaturized device designed to treat ...

Cantor Fitzgerald & Co. has made some new hires to its financial institutions group, including Vishal Sitapara from Jefferies Financial Group Inc. Sitapara was a managing director at Jefferies ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 1.56% of ...